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The o isoforms of the Na+,K’-ATPase (Na’ pump) are expressed with developmental nd tissue heterogeneity in rodents and possess different 
sensitivity to inhibition by ouabain. We directly characterized the ouabain sensitivity of the rat Al(rr2) isoform by tmnsfecting NIH 3T3 cellswith 
rat AZ. The treated cells exhibit high affinity (40 nM) ouabnin binding with a density of 2 pmollmg protein. wRb’ flux studies confirm that A2 
is functional in this system and that A2 is inhibited by submicromolar concentrations of ouabain. These findings are consistent with measurements 
of ouabtlin aftinity in tissues which express the A2 isoform. 
Na’,K’-ATPase: “‘Rb’ flux; Cardiac glycoside; a2 lsoform 
1. INTRODUCTION 
The Na’,K+-ATPase (Na’ pump) is a multi-subunit 
protein essential for the maintenance of the transmem- 
brane ionic gradient in cells, via exchange of three Na’ 
ions for two K‘ ions. this enzyme is composed of a 
catalytic u subunit (-112,000 Da) and a smaller/j subunit 
(-35,000 Da). Currently three a-subunit isoforms are rec- 
ognized, Al (al), A2 (a2), and A3 (a3), and the results 
of recent work indicate a remarkable heterogeneity of 
tissue and developmental expression of these isoforms 
[1,2], Al is ubiquitous and is especially abundant in 
transport epithelia such as kidney; A2 is found predom- 
inantly in muscle and brain, as well as in adipose tissue. 
A3 is appreciably expressed only in neural tissue, as well 
as in fetal heart [3-73. Because the marked variation in 
tissue distribution may be related to functional differ- 
ences among the isoforms, characterization of their in- 
dividual transport properties remains an important goal 
of ongoing studies [S]. 
The cc subunit of the Na’ pump contains an extra- 
cellular binding site for ouabain and other cardiac gly 
cosides, which inhibit enzymatic activity [1,2]. One func- 
tional aspect in which the isoforms markedly differ is in 
a species-dependent diflerence of inhibition by cardiac 
glycosides. Initial studies using gel electrophoresis iden- 
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tified two molecular forms in rat brain characterized by 
either a high affinity (‘CL+‘) or low affinity (‘a’) for 
ouabain [9]. Following the molecular cloning of the 
Na+,K’-ATPase and the identification of three discrete 
a isoforms, it became apparent that the previously iden- 
tified ‘dt’ isoform was distinct (Al), while the ‘CL+’ 
isofortn represented both the A2 and A3 isoforms [IO]. 
These two isoforms are considered to have high affinity 
for ouabain. although direct determination of the 
ouabain sensitivity of each isoform has been difficult 
since A2 and A3 are generally co-expressed in the same 
cells. The A3 isoform has been demonstrated to have a 
high affinity for ouabain by selective trypsinization of 
A2 [I I] as well as through transfection studies [12]. 
Several ines of evidence have suggested that the rat A2 
isoform is also highly ouabain sensitive. First, murine 
C2C12 myotubes express A2 and bind ouabain with 
high affinity [13]. Second, A2 can be made ouabain 
resistant by chimera construction or site-directed mut- 
agenesis, and expressed in mammalian cells [8,14]. 
Third, previous work has indicated that A2 is a major 
isoform in skeletal muscle [4,5] and a correlation exists 
between the amount of A2 present in this tissue and high 
affinity binding of ouabain [lS]. Further, Kjeldsen [16] 
has shown that there is a single component of high 
affinity binding in rat skeletal muscle, which is likely to 
be due to the presence of A2. 
To examine further the ouabain sensitivity of rat A2 
we transfected the A2 gene into a cell line which nor- 
mally expresses only Al, and pharmacologically as- 
sessed the resultant Na’ pump expression. Here we pro- 
vide additional evidence that the rat A2 isoform is a 
distinct Na+,K+ pump, and that it is highly sensitive to 
ouabain with an affinity similar to the A3 isoform. 
Published by Ehwier Science Publishers B, V. 147 
Volume 303, number 2,3 FEBS LETTERS June 1992 
2. MATERIALS AND METHODS 
2. I. Cotfstrucfim of espressiotr vrctol 
An expression vector encoding rat A2 isoform of Nv+.K’-ATPase 
was constructed as follows. A Bluescript (KS+) (Stratagene, La Jolla, 
CA) plasmid containing the cDNA encoding the rat A2 isoform was 
linearized with ffi~tdII1, and the 3’ polyA tail of the cDNA was re- 
moved using BAL-31 nuclease (New England Biolabs, Beverly, MA), 
Hind111 linkers were added and the plasmid was resligated and used 
to transform DH5ol competent cells (BRL. Gaithersburg. MD): 01. 
igonucleotide sequencing (Sequenase; USB, Cleveland OH) confirmed 
that the 3’ end of the A2 coding region still contained the region coding 
for the protein stop site. The 3.1 kb coding region was released by 
EcoRI digestion, 
The plasmid vector pMT-21 (kindly supplied by Genetics Institute, 
Cambridge, MA) which contains a single EcoRI restriction site was 
linearized by EcoRI digestion, treated with calf intestinal alkaline 
phosphatase, and ligated to the A2 cDNA fragment. This was propa- 
gated in DHSa competent cells to generate the 7.8 kb plasmid pMT21~8 
A2 (Fig. I). Restriction analysis conilrmed that the clone contained 
the A2 cDNA in the proper orientation, 
2.2. Ceil culture und DNA trunsfkviott 
NIH 3T3 cells (obtained from ATCC, Rockville, MD) were grown 
in Dulbecco’s modlfied Eagle medium (DME) supplemented with 
glutamine. penicillin, streptomycin. and 10% fetal calf serum (Gibco, 
Grand Island, NY), For transferlion pMTZl-A2 was linearized with 
Nde and co.transfected ata 2O:I molar ratio with circular pSV2neo 
by the modified calcium phosphate precipitation technique described 
by Chen and Okayama [II], using acommercial trunsfection kit (Strat- 
agene). After 45 h cells were split I:6 into 150 mm dishes, and after 
an additional 24 h the medium was replaced with medium containing 
the antibiotic G-418 (Geneticin; Gibeo) at 400 ,@ml to select stable 
transfectants. Individual G~4lS+esistant colonies were subsequently 
isolated and maintained in G-418 containing medium. 
2.3, RNA isolation and blot unaiysis 
Total RNA was prepared from confluent cc!1 cultures by the guani- 
dinium isothiocyanate CsCl gradient method [181. RNA was separated 
by 1% agarose/formaldehyde gel electrophoresis, transferred to Gene 
Screen Plus nylon membranes (New England Nuclear, Boston, MA), 
and hybridized as recommended by the membrane supplier. cDNA 
probes were labeled with [a.“PjdCTP using a multipriming kit (Amer- 
sham Corp., Arlington Heights, IL). ARer initial hybridization, blots 
were re-probed with [a-32P]human pactin cDNA to assure equiva- 
lency of RNA loading. 
2.4. Membrane preporrrtiotl und Western Mot analysis 
To identify expression of A2 protein by transfectants crude micro- 
somal preparations were prepared in a simplified method analogous 
to that of Jorgensen and Skou [19]. Cells were grown to confluence. 
washed twice with phosphate-buffered saline (PBS) at 4OC, and col- 
lected using a rubber policeman in 4 ml of an isotonic buffer [20] (100 
mM KCI, 3 mM NaCI, 1 mM ATP(Na),. 3.5 mM MgC&. 10 mM 
PIPES, I mM EGTA, pH 7.3) containing protease inhibitors (aprot- 
inin I ydml, leupeptin 2pB/ml, PMSF 0.5 mM), They were pelleted 
in a micro.centrifugc (RCF 82 xg, 5 min), resuspended in a small 
volume and then disrupted in a dounce B homogenizer. The nuclear 
material was pelleted (RCF 735 xg, 5 min). and the supernatant 
recentrifuged (RCF 16000 xg, I5 min) to yield a crude microsomal 
pellet which was resuspended in a small volutne. Aliquots of this 
preparation were separated by electrophoresis ona 6.25% SDS-poly- 
acrylamide gel in a Laemmli buffer system [21]. Proteins were electro- 
phoretically transferred to a nitrocellulose membrane and reacted with 
the monoclonal antibody M&2 (kindly supplied by K, Sweadner) 
which is specific for the A2 isoform of the Na’,K+-ATPase [IO]. Col- 
orimetric development of the Western blot by alkaline phosphatase 
was carried out by standard procedures using a commercial kit 
(Promega, Madison, WI). 
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2.5, Otruhuitz bittrlitq studies 
To assess ouabain affinity and functional characteristics of the A2 
isoform, both intact cell ouabain binding studies and nbRb’ flux studies 
were performed. 
Binding of outtbain to intact cells was accomplished using a tech- 
nique modified from previously published methods [13,22]. Briefly, 
I x IO’ cells were seeded per 35 mm well on multi-well tissue culture 
plates and grown to near confluence overnight at 37°C. 5% CO:. in 
DME-10% FCS, The culture medium was removed and the cells 
washed twice with 2.5 ml of K+- and Ca2+-free HEPES-NaOH-buff- 
ered saline solution at 37’C (HBSS: 20 mM HEPES-NaOH, 130 mM 
NaCI, 0.5 mM MgCl:, 0.2 mM Na,HPO,, 0.4 mM NaH,PO,, pH 7.4). 
The cells were then incubated with 0.5 ml of HBSS containing 25 nM 
to 400 nM [‘Hlouabain (18.0 Ci/mmol ouabain; Amersham) in the 
absence (total binding) or presence (non-specific binding) of 400pM 
unlabeled ouabain for 30 min at 37°C. since preliminary experiments 
established that specific binding saturated by 30 min and remained 
stable for at least 90 min under the K+-free conditions employed. 
Following incubation, the [‘Hjouabain HBSS was removed, and the 
cells washed twice with 2.5 ml of HBSS at 4OC for 10 min each. The 
cells were removed from the wells with a rubber policeman in 0.4 ml 
HBSS, and radioactivity was determined by liquid scintillation count- 
ing. Specific [“Hlouabain binding was calculated by subtracting non- 
specific binding from total binding. Parallel wells were washed and 
incubated identically with HBSS, and aliquots were used for protein 
determination using the BCA protein assay (Pierce, Rockford, IL). 
Binding analysis was performed using the EBDA program adapted by 
McPherson [23] from Munson and Rodbard [24]. 
For dissociation experiments. multiple sets of plates were incubated 
with 200 nM [‘Hlouabain for total binding or non-specific binding as 
above, and individual wells analyzed at time points prior to and sub- 
sequent o addition of 200 PM unlabeled ouabain. 
2.6. Transport studiex 
K’ uptake into stable transfectants and control cells was assessed 
using *RB+ as a tracer, as modified from published methods [25]. 
Briefly, 0.3-0,6 x 10’ cells were seeded 2&48 h prior to study onto 35 
mm tissue culture dishes, and maintained at 37°C 5% COr. The cells 
were washed twice and then pre-incubated for 60 min at 37°C 5% 
COz, with I ml of K’-free Earle’s solution with choline chloride sub- 
stituting for KCI, in order to facilitate internal Na’ loading and sub- 
sequent stimulation of the Ns+,K’-ATPase (‘preload solution’: 140 
mM NaCI, 25 mM HEPES, 54 mM choline chloride, I .8 mM CaCIz, 
0.8 mM Mg!jO*, 5.5 mM dextrose, buffered to pH 7.4 with 1 M 
TrismHCI). At 60 min the preload solution was aspirated and 1 ml of 
K+-containing Earle’s solution (5.4 mM K+) also containing I-2@i/ 
ml of “6RB+ (Amcrsham) and varying concentrations ot’ouabain, was 
added to the cells (‘uptake solution’). Preliminary studies indicated 
that as much as 70% of K* uptake was not inhibited by ouaba:n. but 
was virtually abolished by the addition of bumetanide (100 PM in 
DMSO; Leo Pharmaceutical Products, Denmark), which inhibits the 
Na*/K+/2CI- cotransporter [26]. Therefore all subsequent studies were 
carried out in the presence of 100 PM bumetanide to allow specific 
assessment of the Na’ pump. Uptake proceeded for 2-6 min at 37OC 
and was terminated by aspirating the uptake buffer and rinsing 
quickly 3 times with 0.1 M MgCI: at 4°C. After the =ul:ures were 
air-dried I ml of 10% TCA was added and aliquots removed for 
radioactivity determination by liquid scintillation counting. Uptake 
was expressed as nmol of K’ per IO6 cells based on the known K’ 
concentration of the uptake buffer. Parallel plates were handled in the 
same manner and cell number determined using a Coulter counter 
(Coulter Electronics Inc., Hialeah, FL). 
3. RESULTS 
3.1. Expression of A2 lsofonn RNA in trunsfected ceh 
The plasmid vector pMT21 is an adeno-driven vector 
capable of high expression in mammalian cells [27], and 
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Fig. I. Structure of expression vector pMT2I-A2. A 3.1 kb cDNA 
fragment encoding rat Na+,K+-ATPase A2 isofomi was inserted at the 
EcoRl site of the vector pMT2I. The plasmid contains an SV40 origin 
and enhancer segment, he adenovirus major late promotor. and oiher 
cukaryotic regulatory elements designed to cnhancc expression in 
mammalian cells [23]. 
we have used it to develop a stable expression line in 
NIH 3T3 cells. A new expression vector encoding the 
rat A2 isoform of Na’,K+-ATPase was constructed and 
designated pMT21-A2, and was used for transfection 
(Fig, 1). As described above, in NIH 3T3 cells which 
were co-transfected with pSVZneo, we obtained 18 G- 
41 S-resistant clones after 4-6 weeks and prepared RNA 
from them at that time. Fig, 2A demonstrates a North- 
ern blot of RNA from transfected and control cell lines, 
probed with rat A2 cDNA, under conditions which 
eliminate cross-hybridization with other highly homolo- 
gous Na+,K+-ATPase isoforms [6]. Lane 1 shows the 
absence of A2 RNA in wild-type NIH 3T3 cells, while 
lanes 2 and 3 indicate the presence of A2 RNA in two 
stable clones (clones no. 3-6 and no. 3-10). Lane 4 dem- 
onstrates that A2 is not expressed in another of the 
selected clones (clone no. 3-2). Lane 5 shows RNA from 
rat brain which is known to express A2 [4]. Note that 
the AZexpressing transfected cells all have a single A2 
transcript (-4 kb) resulting from expression of the trans- 
fected piasmid, while brain has two characteristic A2 
transcripts at -3.4 and -5.3 kb. Of note, Western analysis 
(see below), showed corresponding presence of protein 
in clones no. 3-6 and no. 3-10, and absence in no. 3-2. 
3.2. Protein expression in rransfecred cells 
To demonstrate that A2 mRNA presence was associ- 
ated with appearance of mature A2 protein at the cell 
membrane, Western blot analysis was performed on 
crude microsomes prepared from a series of the stable 
cell clones. To accomplish this, we used rat monoolonal 
antibody M&2, which reacts specifically with A2 
isoform protein [IO]. As noted above, 18 independent 
G-418-resistant clones were obtained 4-6 weeks after 
co-transfection; all were analyzed for presence of A2 
protein, and 7 clones were positive. Fig. 3 shows a com- 
posite of Western blots examining 5 of the clones. Lanes 
B 
.L ,. 
1 2 3 4 5 
Fig. 2. Northern blot hybridization.Total RNA (lOyg/lane) prepared 
from wild-type NIH 3T3 cells, from stable clones derived from NIH 
3T3 cells transfected with pMT21-A2, and from rat brain was sepa- 
rated by gel clectrophoresis and transferred to a nylon membrane, (A) 
Hybridization with rat Na+,K’-ATPasc A2 isoform cDNA. A2 RNA 
is not expressed ineither wild-type 3T3 cells or clone no. 3-2. A2 RNA 
is expressed with a single trancxript at -4 kb in clones no. 36 and no. 
3-10. Specificity is confirmed by the presence of signal in rat brain 
(with 2characteristic transcripts at -3.4and-5.3 kb).(B) Hybridization 
with human y-acrin cDNA. A sin& band of approximately equal 
intensity is seen in each lane. The positions ofthc 28 Sand 18 S rRNAs 
are indicated. 
1,3,4 and 5 show a band at about 112,000 M, consistent 
with the A2 isoform; this band is similarly present in 
lane 8 which contains microsomes from rat brain. Note 
the absence of reactive protein in lane 2 (clone no. 3-2), 
lane 6 (wild-type NIH 3T3 cells) and lane 7 (rat kidney). 
Similar results were obtained with analysis of the tran- 
sient transfection assays (data not shown). 
Based on the protein and RNA presence, subsequent 
studies of Na+,K”-ATPase activity were performed 
mainly using positive clone no. 3-6. Control studies 
were performed with both the transfected but non-ex- 
pressing clone no. 3-2, as well as with wild-type NIH 
3T3 cells. 
3.3. Measurement of[JH]ouabain binding in iratasfected 
and conrrol cells 
Clone no. 3-2, which did not express A2, exhibited 
virtually no specific binding during incubation with 
[‘Hlouabain at concentrations ranging from O-400 nM 
ouabain, as expected (Fig. 4). Similar results were ob- 
served using wild-type NIH 3T3 cells (data not shown). 
In contrast, transfmted clone no. 3-6 showed significant 
ouabain binding even at low concentrations of ouabain 
(25 nM). There was a progressive increase in specific 
binding with increasing ouabain concentrations, which 
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Fig, 3, Protein expression of transfected and wild-typ cells. Crude 
microsomes were prepared from stable cell clones derived from NIH 
3T3 cells transfected with pMT2l-A?, wild-type 3T3 cells, and ret 
kidney and brain. Proteins were separated on a 6.25% SDS-poly- 
acrylamide gel, transferred to a nitroccllulose filter, and stained wiih 
monoclonal antibody to A2 isoform (McB2) at I :7SO. A band at about 
1 I?,000 Y, consistent with A? isoform is present in microsomes from 
four clones, as well as from rat brain. This protein is absent in prcpa- 
rations from one clone, wild-type eels, and rat kidney. Subsequent 
studies on A2 binding and transport activity used mainly positive 
clone no. 3-6, and used clone no. 3-2 as a non-expressing control. The 
positions of the molecular mass markers are indicated. 
approached saturation at 400 nM ouabain. This specific 
binding, attributed to the presence of A2 isoform pro- 
tein, was characterized by a Kd of 40 nM (Fig. 4, insert) 
and a B,,,, of 2 pmol/mg protein. 
To confirm that the binding was reversible as well as 
specific, dissociation of bound [‘Hlouabain by unla- 
beled ouabain was measured. After 30 min of incuba- 
tion with 200 nM [‘Hlouabain, the medium was re- 
placed by medium containing 200 PM non-radiolabeled 
ouabain, This resulted in a rapid decrease in bound 
[‘Hlouabain, of -50% after 15 min, and of >90% after 60 
min (data not shown). 
3.4. Na’,K+-ATPase clctivity in transfected and corttrol 
ceh 
We found that pre-incubation of the cells with a K+- 
free buffer (‘pre-load solution’) for 60 min markedly 
stimulated K’ uptake in either transfected or control 
cells (e.g. increasing pre-load time from 15 to 60 min 
increased uptake by -75-904s; data not shown). Subse- 
quent studies were performed with a 60 min pre-incuba- 
tion time. K’ uptake (in the presence of bumetanide) 
was linear in both A2-expressing clone no. 3-6 cells and 
non-A2-expressing clone no. 3-2 cells for at least 6 min, 
and was markedly inhibited (-90% of control) by i mIvi 
ouabain (Fig. 5). Total uptake was similar for trans- 
fected or control eels, although there was a tendency for 
slightly greater uptake in the control cells. 
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Pig. 4. Comparison of [‘Hlouubain binding in transfected and control 
cells. Non-A!. expressing clone no. 3-Z cells and AZexprcssing clone 
no. 3-6 cells were incubated for 30 min at 37°C with varying concen- 
trations of [“Hlouabain, then washed twice for 10 min at 4°C with 
ouabain-free buffer, Cells were collected and radioactivity determined 
by scintillation counting. Specific binding is total minus non-specific 
binding, per mg protein. Clone no. 3-6 cells (closed squares) show 
progressive increase in binding with increase in ouabain conccntra- 
tion. Clone no. 3-2 cells (open squares) show ~246 of maximal binding 
of A2 transfected cells (clone no. 3-6). Each curve is the mean t S,D. 
of two experiments. Inset: Scatchard analysis (B, bound; F, free) of 
[“Hlouabain binding, normalized per mg protein (mean 0.73 mgAvell). 
The f& is 40 nM, and the B,,,, is 2 pmollmg protein. 
Next, the effect of ouabain concentration on K’ up- 
take was studied in transfected and control cells. Fig. 6 
demonstrates that in control cells (clone no. 3-2) there 
was no effect on K’ uptake until at least 50 yM ouabain 
was added. In contrast, A2-expressing transfected cells 
(clone no. 3-6) were significantly inhibited at concentra- 
tions as low as 0,l yM ouabain, with an I& of -5 FM. 
These findings were substantiated by additional study 
of two other transfected clones which were positive for 
A2 protein by Western analysis (clones no. 3-4 and no. 
3-10). Interestingly, clone no. 3-10 showed less inhibi- 
tion of K’ uptake by low ouabain concentration than 
no. 3-6 (10% vs. -30% inhibition at 0.5puM ouabain, data 
not shown), and correspondingly expressed less A2 
RNA (Fig. 2). In contrast, both wild-type NIH 3T3 cells 
and non-A2-expressing transfectants which were nega- 
tive for protein by Western blot showed no effect at 
submicromolar ouabain concentrations. 
4. DISCUSSION 
Prior work has clearly shown that rodents are unique 
in having Na’,K’-ATPase which displays two markedly 
different affinities for ouabain, attributed to the pres- 
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ence of different a-subunit isoforms, More recently, 
studies have indicated that both A2 and A3 are appar- 
ently ouabain sensitive. Our goal was to use a transfec- 
tion model to further examine the A2 isoform. We 
therefore first determined whether A2 was functional in 
our system. Second, we asked whether A2 was inhibita- 
ble by ouabain, and if so, whether it displayed a low 
ouabain sensitivity comparable to Al, or a high sensi- 
tivity. 
Early work by Sweadner in rat brain tissue identified 
two distinct classes of ouabain sensitivity associated 
with two molecular forms of the Na”,K”-ATPase as 
resolved by gel electrophoresis, with a ouabain-resistant 
form (a) and a ouabain-sensitive form (a+) [9]. More 
recently there has been characterization of these high 
affinity binding sites in specific locations of the rat and 
rabbit central nervous system [28,29], as well as from 
adipose cells [30], and rat soleus muscle [16]. However, 
the molecular cloning of three distinct Q isoforms led to 
the understanding that the earlier described ‘a+’ 
isoform likely comprised both A2 and A3 isoforms, 
with the relative amounts of each dependent on the 
tissue studied [lo], Additionally, a recent finding of two 
separate high affinity sites in rat brain is consistent with 
this concept and implies that A2 and A3 have similar 
but unique affinities [31], Confirmation that A3 was 
indeed a high affinity form was reported by Hara et al. 
via transfection studies of A3 cDNA [12]. Recently, 
data has accumulated regarding the characteristics of 
the A2 protein as well. Orlowski and Lingrel, studying 
a murine myogenic ell line, found a marked induction 
of A2 mRNA during fusion of proliferating myoblasts 
to form myotubes, accompanied by an increase in high 
affinity ouabain sites and in ouabain-inhibitable 
Na+,K+-ATPase activity 1131. Also Hsu and Ciuidotti 
[15] studied Na’,K+-ATPase in skeletal muscle from 
hypokalemic rats and found a correlation between lev- 
els of A2 isoform and the ouabain sensitive fraction of 
the pump. Kjeldsen has demonstrated a single compo- 
nent of high affinity ouabain binding in rat skeletal 
muscle [16] which is likely A2 based on prior studies 
[4,5]. Additionally it has been found that specific amino 
acid residues within the Hl-H2 extracellular domain of 
the alpha subunit are critical for ouabain resistance [32], 
and several groups have altered A2 cDNA in these re- 
gions to produce ouabain resistant forms of A2 
[8,14,33]. 
We approached the issue of ouabnin sensitivity with 
the specific aim of expressing A2 in a cell which did not 
express endogenous A2 or A3, to allow for a direct 
assessment of ouabain sensitivity. We transfected a 
plasmid construct containing A2 into ouabain-resistant 
NIH 3T3 cells and confirmed high ievels of A2 expres- 
sio?? by Northern and Western blots (Figs. 2 and 3). 
Previous work has shown two RNA transcripts for A2 
in rat brain, of about 3.4 and 5.3 kb, as a result of 
multiple polyadenylation sites [3,4]. The size of the sin- 
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Fig. 5. Effect of uptake time on K’ uptake by Na*.K’-ATPase. AZ- 
expressing clone no. 3-6 and non-A2-expressing clone no. 3-2 cells 
wcrc rinsed and then preincubateci for 60 min at 37OC with K--free 
EBSS. Then WbRb+-EBSS bulI’er containing bumctanide (‘uptake 
buffer’) was added and uptake proceeded for 2,4, or 6 min in absence 
(-) or presence (+) of I mM ouabain. Uptake was stopped. cells 
precipitated, and “Rb’ uptake determined. *Rb+ uptake was con- 
verted to K’ uptake/IO6 cells based on known K’ concentration of the 
medium. Uptake was linear for at least 6 min in both clones (closed 
symbols). and was inhibited by -90% ofcontrol at all uptake times by 
1 mM ouabain in both clones (open symbols). 
gle RNA transcript seen in the transfected cells is 
slightly larger than the 3.4 kb transcript, with the slight 
increase in size accounted for by the transcription of 
additional plasmid RNA including a DHFR region and 
an SV40 polyadenylation site at the 3’ end (Fig. 1). 
Studies of ouabain binding in these transfected cells 
indicate that the A2 isoform is indeed highly ouabain- 
sensitive, with a Kd of 40 nM (Fig. 4). 
‘This dissociation constant for ouabain determined 
for A2 is comparable to reports of high affinity binding 
obtained in several other tissues. In rat soleus muscle, 
which expresses predominantly A2 [4,5], and therefore 
should be similar to our model, Kjeldsen reported an 
apparent Kd for auabain binding of -40-70 nM [ 161. We 
found rat A2 characterized by a B,,,, for ouabain of -2 
pmoYmg protein, results which compare well to reports 
for high affinity binding in rat brain (7.6 pmoYmg pro- 
tein) [28]. Kjeldsen report:d from rat soleus muscle a 
S,,,,, of -0.3 pmol/mg wet wt; [I61 this would be higher 
and perhaps closer to the value we found if expressed 
per mg protein. In rat brain, which expresses all three 
d: isoforms, Berrebi-Bertrand et al. recently described 
finding three distinct ouabain affinities: two of high 
affinity with KJ values of 17 nM (‘very high’) and 80 nM 
(‘high’), and one of low affinity [31]. Each of these high 
affinity sites represented about one-third of the totai 
ouabain binding sites. Comparing this study with our 
findings that rat A2 has a Kd of 40 nM, along with 
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Fig, 6, Ouabain inhibition of K’ uptake by Na+,K+-ATPase in trans- 
fected and control cells: effects of varying ouabain concentration. 
Cells were rinsed and preincubatcd for 60 min at 37°C with K-free 
EBSS. and then incubated with uptake buffer for 6 min in the presence 
of varying concentrations of ouabain. Uptake was stopped. cells pre- 
cipitated, and nbRb’ uptake determined. TLb’ uptake was converted 
to K+ uptake/IO6 ceils based on known K’ concentration of the me- 
dium, and expressed as % of uptake occurring in each cell clone in the 
absence of ouabain. (Maximal uptake in the absence of ouabain was 
17.4 4 0.6 nmol K+/106 cells for the no. 3-6 cells, and 22.5 + 0.8 nmol 
K+/IOb for the no. 3-2 cells.) Non-A2-expressing control cells (clone 
no. 3-2, open bars) showed no inhibition of uptake until at least 50 
yM ouabain was added. A2-expressing tnnsfcctants (clone no. 3-6, 
solid bars) showed significant inhibition at ouabain concentrations as 
low as 0. I AM; the IC, was -5,~uM. Each curve is the mean + SD. of 
triplicate determinations from a representative experiment, rcpcated 
three times. 
evidence that rat A3 has a Kd of80 nM [ 121, it is possible 
that A2 accounts for the ‘very high’ and A3 for the 
‘high’ afhnity sites. This would require direct compari- 
son in a transfection model for confirmation. Thus the 
A2 and A3 isoforms together likely account for the high 
affinity binding noted in earlier studies, and the relative 
amounts of these two isoforms expressed in individual 
tissues will determine the overall sensitivity for ouabain 
inhibition in that tissue. Because of their similarity in 
ouabain binding affinity, it is important that studies of 
high affinity binding in tissue preparations be correlated 
with either RNA analysis or Western blotting using 
antibodies which do not show cross-hybridization be- 
tween A2 and A3. 
The binding curve for A2 in the transfected cells 
shows that binding is saturable. Additionally, binding 
is reversible and dissociation requires many minutes 
(data not shown); this long dissociation time is also 
consistent with binding of high affinity. Further, these 
data indicate that the bound ouabain is not interna!ized 
by the cells in significant amounts, since >9O% of bind- 
ing is displaced after 60 min. This is consistent with the 
finding that ouabain resistance is related to one of the 
extracellular domajns of the a subunit [8,14,33], and 
that ouabain may not require internalization for its ef- 
fect on enzyme activity. 
The finding of high affinity ouabain binding in the 
transfected cells is complemented by studies using 
ouabain inhibition of “‘Rb’ flux. @RB’ is a valid tracer 
for K’ uptake [25,34] and has been frequently used to 
demonstrate nzyme activity. Our studies how that the 
A2 protein in transfected cells is functional and that low 
concentrations of ouabain (O,l-10 PM) inhibit “Rb+ 
flux only in the transfected cells (Fig. 6). With increas- 
ing ouabain concentrations, increasing amounts of A2 
protein bind ouabain with additional inhibition of activ- 
ity, and only at still higher concentrations (350yM) is 
the endogenous Al activity inhibited. 
These flux studies were performed in the presence of 
bumetanide to inhibit the Na+/K*/2CI- cotransporter, 
since our preliminary experiments indicated up to 70% 
of *6Rb+ uptake was inhibited by addition of the specific 
antagonist bumetanide. This is a higher level of 
ouabain-resistant K’ uptake than is often seen, but high 
levels of ouabain-resistant K’ uptake have previously 
been reported in fibroblasts, particularly after serum- 
stimulation [35]. In general, levels of Na+/K+/2Cl- 
cotransporter activity (total 86Rb+ uptake minus 
ouabain-inhibitable uptake) were comparable in the 
transfected and control cells (data not shown). The re- 
mainder of the flux in our experiments was sensitive to 
inhibition by ouabain at high concentration (I mM), as 
would be expected for both ouabain-sensitive and -resis- 
tant isoforms of the Na’,K+-ATPase. Further, the 
ouabain-inhibitable flux war; comparable between 
transfected and control lines, although there was typi- 
cally a slightly greater level in the non-A2-expressing 
clone (Fig. 5). 
We chose to carry out the flux studies after stimula- 
tion of the Na’ pump such that K’ uptake would occur 
at a rapid and constant rate. Several methods of stimu- 
lation of the Na’ pump have been described including 
use of a low K’ bath, use of agents which affect trans- 
membrane potentials, and temperature ffects [36]. We 
found that pre-incubation with a K+-free medium mark- 
edly stimulated subsequent flux occurring in a physiol- 
ogic K’ concentration, Flux was linear under these con- 
ditions for both control and transfected cells (Fig. 5). 
Thus, we do not ascribe differences in “Rb+ flux ob- 
served at low ouabain concentrations to differences in 
i’m,, of the enzymes. 
Both the ouabain binding and “Rb+ flux studies were 
performed on stable clones isolated by selection in G- 
418. Because transfection itself could conceivably in- 
duce changes in ouabain binding or Na” pump activity, 
as control cells we examined both wild-type 3T3 cells 
which do not express A2 isoform, as wel! as ce!!s trans- 
fected and selected in G-418 but which did not achieve 
expression of A2 protein. These latter cells were thus 
exposed to identical conditions as the A2-expressing 
152 
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clones throughout the time period of the experiments. 
These non-A2-expressing cells and the wild-type 3T3 
cells were indistinguishable. 
It is interesting that total Na’ pump activity in the 
transfected and control cells was comparable (Fig. 5). 
This finding suggests that total pump activity is regu- 
lated in the transfected cells, with a decrease in the 
amount of endogenous Al pump activity as a function 
of the presence of A2. In addition, study of two different 
AZexpressing transfected clones (no. 3-6 and no. 3-10) 
revealed that a higher level of A2 RNA expression was 
associated with a greater percentage of inhibition of 
Na’,K’-ATPase at low ouabain concentrations. This is 
consistent with regulation of Al either at the transcrip- 
tional or post-translational level. Alternatively, limiting 
amounts of B subunit protein may be present and be 
preferentially complexed with A2 in these cells. Further 
experiments are required to evaluate and confirm these 
possibilities. 
In summary, we have used a mammalian cell trans- 
fection model to directly study the ouabain sensitivity 
of the rat A2 isoform, The results demonstrate that A2 
binds ouabain with high affinity and that its transport 
activity is inhibited by ouabain at submicromolar con- 
centrations. This confirms that each of the three known 
cz isoforms have distinct ouabain affinities, with A2 and 
A3 having very similar binding equilibrium constants. 
This model may also be useful in further studies on 
Na’,K+-ATPase isoform regulation and in analyses of 
specific coding regions of the isoforms. 
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